LGD-3303 is offered in 17mg/ml concentration. Each bottle contains at least 30ml of total volume resulting in 500mg of LGD-3303 per bottle.
LGD 3303 is a research compound being investigated for its potential to selectively bind to androgen receptors in muscles and bones, which may provide a safer treatment for osteoporosis than current medications. Studies have found LGD-3303 to be a powerful and highly selective androgen receptor agonist in skeletal muscle, while being a much weaker partial agonist in sebaceous glands and prostate.
|CAS Number||917891-35-1, 1196133-39-7|
|Molar Mass||342.75 g·mol−1|